Belvedere Trading LLC Immunity Bio, Inc. Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $10,886 - $38,545	-8,064 Reduced 40.5%	11,846 $21,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $9,252 - $14,399	2,127 Added 11.96%	19,910 $100,000
Q3 2022 Oct 26, 2022	SELL	$3.65 - $6.43 $605 - $1,067	-166 Reduced 0.92%	17,783 $96,000
Q2 2022 Jul 21, 2022	BUY	$2.68 - $6.14 $48,103 - $110,206	17,949 New	17,949 $78,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.